Corporate Presentation: Internet of Things Innovator, Direct Communication (DCSX).
CORPORATE PRESENTATION | 8-2022
#DCSX
This release contains forward-looking statements, which reflect management's current views of future events and operations. These statements are based on current...
Adding Iconic Brands (ICNB) $0.20 to Watch List.
Added Iconic to the Beverage Stock Review Watchlist, "Top Beverage Stocks for 2022 and Beyond."
Before month end, we will come out with...
13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)
RAPS' Latest | 01 August 2019 | By Zachary Brousseau
When the US Food and Drug Administration (FDA) has significant questions or concerns about clinical data...
DCS (DCSX) Announces Closing of Fully Subscribed USD $1.5 Million Private Placement Financing.
San Diego, California--(Newsfile Corp. - September 9, 2022) - Direct Communication Solutions, Inc. (OTCQX: DCSX) (CSE: DCSI) (FSE: 7QU), a leading provider of information technology...
Adding Progressive Care (RXMD) $0.04 to Watch List.
Adding to Biotech Stock Review 2022 Watch List.
Speculative, Yes. But Pay Down of $2 Million Toxic Note and Move into Remote Patient Monitoring Makes...
CB Scientific, Inc. (CBSC) Announces FDA 510(k) Submission.
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
Updated product to include significant operating improvements and material design advances over...
Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules Capital
Don't think we've ever seen anything like this before. Most investors who prefer to invest post FDA approval, invest post FDA approval. They got...
OnFolio Holdings Inc. (ONFO) Announces Pricing of $13.7 Million Initial Public Offering and Nasdaq...
Nice work by EF Hutton. We like this business model. Similar to old school incubator, but they acquire rather than invest and assist.
PRELIMINARY...
Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...
VERU Inc. (VERU) $24. High Risk, Minimal Reward?
Pre-FDA Approval Play. The Shares Are Now in the Hands of Fast Money Traders.
You Can't Kiss all the Pretty Girls, But Revive Therapeutics (RVVTF)...
Latest article
Who’s the Next Eric Sprott?
To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...
Perpetua (PPTA) Raises $300 Million.
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
Brixton Metals (BBBXF) $0.072, Leaps 62%. On No News.
Institutional Gold Analyst
It's always fun to decide on a single word, to describe a 62% single day price gain. Should we use "rose, surged,...
